A Biomimetic Lung On A Chip For Drug Studies | 12223
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

2nd International Conference on Biotechnology and Healthcare

Auckland, New Zealand

6th International Conference on Vaccines and Immunology

Geneva, Switzerland

3rd European Congress on Virology

Geneva, Switzerland
Google scholar citation report
Citations : 1600

Journal of Biotechnology & Biomaterials received 1600 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

A biomimetic lung on a chip for drug studies

4th World Congress on Biotechnology

Sonia Grego

Accepted Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.S1.025

A microfluidic multicellular model of the human conducting airways has been developed for drug response and disease modeling studies. The airways are a primary site of exposure to environmental insults and pathogens, as well as an attractive drug delivery route. A biomimetic culture of multiple lung cell types was engineered in a microfluidic device to more closely emulate the in vivo morphology and function of the airway tissue and its vasculature. This approach relies on all primary human lung cells with the objective of providing a more predictive in vitro model of human lung physiology. This cellular construct enables analysis of complex response pathways involving paracrine signaling across cell types and studies of drug response and viral infections are ongoing.